Matches in Nanopublications for { ?s ?p "[EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposomes in orthotopic models of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP777250.RAtLSnxOkzRQMs70iJnL6CzTudzET7_kS1N3334umepgM130_assertion description "[EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposomes in orthotopic models of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP777250.RAtLSnxOkzRQMs70iJnL6CzTudzET7_kS1N3334umepgM130_provenance.
- NP365752.RAqI2oUSyqtT1nguRxW9nsFYYugDX4kTKWeRlch4e9_PE130_assertion description "[EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposomes in orthotopic models of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365752.RAqI2oUSyqtT1nguRxW9nsFYYugDX4kTKWeRlch4e9_PE130_provenance.
- NP711988.RAVv2fpUoPtukmWoAEt_Z5BZGo_YFOtGqPqKkzJFcdIqo130_assertion description "[EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposomes in orthotopic models of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711988.RAVv2fpUoPtukmWoAEt_Z5BZGo_YFOtGqPqKkzJFcdIqo130_provenance.
- assertion description "[EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposomes in orthotopic models of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposomes in orthotopic models of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_assertion description "[EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposomes in orthotopic models of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734854.RAdlb7z1HIymALv1uU40h1UXn1C8QknDEJ_CVpHyFF1Bs130_provenance.
- NP712061.RAPud1KVmJYXrj-jVD6aGF7q4-fplzPJouYVI1qod062Q130_assertion description "[EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposomes in orthotopic models of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712061.RAPud1KVmJYXrj-jVD6aGF7q4-fplzPJouYVI1qod062Q130_provenance.
- NP734853.RAKtoogsevzn0NIrgEAtKbLwXt0Oytehne1vdTH1I5p6w130_assertion description "[EphA2 targeted siRNA was tested in combination with either FAK or Src targeted siRNA using DOPC nanoliposomes in orthotopic models of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734853.RAKtoogsevzn0NIrgEAtKbLwXt0Oytehne1vdTH1I5p6w130_provenance.